The NTG has put together a library of publications regarding clinical trials and other miscellaneous drug information of general value and those regarding dementia and intellectual disability.
Drug label information
FDA Approves use of Leqembi for Alzheimer's
Closure on Biogen's Aduhelm Launch - Congressional Report
ENACT Act Will Help with Inclusion in Clinical Trials
Biogen announces positive results for Alzheimer's drug Lecanemab
Disappointing Results from Amyloid Reducing Drug Trial
NTG Video on Biomarkers and Therapeutics for People with Down Syndrome and Alzheimer's Disease